All In MedTech

Device Trial Radar · NCT07078071

Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software

Last checked: Nov 19, 2026Latest source record: Jul 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

199

Actual

Start

Oct 18, 2022

Primary completion

Mar 1, 2023

Study completion Mar 1, 2023

Sponsor

Lead sponsor
Huawei Device Co., LtdNot on our public-company list
Sponsor type
Industry
First posted
Jul 22, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study aims to validate the efficacy and safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software (Huawei Device Co., Ltd.). This software can provide alerts, store and display PPG data transmitted from smartwatches or fitness trackers. The software is limited to alerting of atrial fibrillation and premature beat, and the results are only for clinical reference.

Conditions

  • Arrhythmia, Heart

Interventions

  • ECGDevice

    Each participant undergoes testing with both the investigation device and the control device simultaneously. The results of the investigation device, which are obtained through pulse wave data analysis at the wrist, are compared to the investigator's interpretation of the ECG.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity and specificity of atrial fibrillation identification in a single measurementTime frame: 45seconds
  2. Sensitivity and specificity of premature beat identification in a single measurementTime frame: 45seconds

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.